|
Overview
This symposium will provide an opportunity for the MRI community
to share the latest information on this emerging disease
complex,
the relationship to the administration of contrast
material, and implications for clinical and research policies.
13:30 Nephrogenic Systemic Fibrosis: What is it, and
where does it come from?
Shawn
Cowper, Yale University, New Haven, CT, USA
13:50
Relation to GD Exposure and on Differences among GD Chelates
Henrik S. Thomsen, Copenhagen University,
Copenhagen, Denmark
14:10 Consequences for the MR Community – Alternative
Diagnostic Pathways
Peter Dawson, University College, London, England, UK
14:30 Legal and Regulatory Issues/The View of the
U.S. Food & Drug Administration
Panos Tsintis/Doris Stenver, EMEA -
sector of Pharmacovigilance, London, UK - via teleconference
14:50 Roundtable Panel Discussion
All Speakers and Harm Peters, Nephrologist - University
Hospital Charité, Berlin, Germany
|